10 Uranium And Nuclear Power Stocks To Watch Amid Musk, Dorsey Voicing Support And Kazakhstan Protests
Uranium and nuclear stocks are in the spotlight with several news items leading to investors searching for stocks with exposure to the sector.
61 Biggest Movers From Yesterday
Gainers
Genprex, Inc. (NASDAQ: GNPX) shares surged 167.2% to settle at $3.50 on Monday. The FDA granted Fast Track Designation for Genprex’s lead drug candidate, Reqorsa Immunogene combination therapy.
35 Stocks Moving In Monday’s Mid-Day Session
Gainers
Immix Biopharma, Inc. (NASDAQ: IMMX) shares climbed 110.3% to $7.32. The FDA granted Rare Pediatric Disease (RPD) designation to newly listed Immix Biopharma's IMX-110 for rhabdomyosarcoma, a form of pediatric cancer.
Mid-Morning Market Update: Markets Open Higher; AutoZone Tops Q1 Views
Following the market opening Tuesday, the Dow traded up 1.52% to 35,761.30 while the NASDAQ rose 2.84% to 15,656.94. The S&P also rose, gaining 2.04% to 4,685.39.
Uranium Royalty Corp. Enters Into Strategic Supply Stream With CGN Global
Uranium Royalty Corp. (NASDAQ:UROY) (TSXV:URC) is pleased to announce that it has entered into a Supply Stream Agreement with CGN Global Uranium Limited to purchase 500,000 pounds of U3O8 from CGN delivered at Cameco
Mid-Morning Market Update: Markets Mostly Lower; Best Buy Posts Upbeat Q3 Earnings
Following the market opening Tuesday, the Dow traded up 0.02% to 35,627.53 while the NASDAQ fell 0.58% to 15,762.28. The S&P also fell, dropping 0.14% to 4,676.49.
HC Wainwright & Co. Maintains Buy on Uranium Royalty, Raises Price Target to $5
HC Wainwright & Co. analyst Heiko Ihle maintains Uranium Royalty (NASDAQ:UROY) with a Buy and raises the price target from $3.7 to $5.
53 Biggest Movers From Yesterday
Gainers
DICE Therapeutics, Inc. (NASDAQ: DICE) shares surged 117% to settle at $36.89 on Wednesday as the company priced its IPO at $17 per share.